# Akari Therapeutics Plc: Form S-1, filed May 8, 2026

- Company: [Akari Therapeutics Plc](/companies/aktx.md) (CIK 1541157)
- Form: S-1
- Filed: 2026-05-08
- Accepted by EDGAR: May 8, 2026, 17:08 ET
- Period: not reported
- Accession: 0001493152-26-022019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1541157/000149315226022019/forms-1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1541157/000149315226022019/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1541157/000149315226022019/forms-1.htm

Filed May 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-022019. Last ingested by Listed: Nov 14, 2026, 14:34 ET. No prices; not investment advice.
